{"pmid":32279655,"title":"Can Hepatitis A Vaccine Provide Protection Against COVID-19?","text":["Can Hepatitis A Vaccine Provide Protection Against COVID-19?","Exp Clin Transplant","Sarialioglu, Faik","Belen Apak, Fatma Burcu","Haberal, Mehmet","32279655"],"journal":"Exp Clin Transplant","authors":["Sarialioglu, Faik","Belen Apak, Fatma Burcu","Haberal, Mehmet"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32279655","week":"202016|Apr 13 - Apr 19","doi":"10.6002/ect.2020.0109","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663989232677421056,"score":7.979339,"similar":[{"pmid":32253172,"title":"Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?","text":["Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?","Since December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19), has posed a serious threat to global health and is currently causing a major pandemic. While patients typically present with fever and a respiratory illness, mounting evidence indicates that patients might also report extra-pulmonary manifestations, including those affecting the liver and gastrointestinal tract. This involvement may have important implications to the disease management, transmission, and prognosis, especially in patients with pre-existing hepatic or digestive co-morbidities. In this review, the characteristics and possible explanations of hepatic and gastrointestinal involvement caused by SARS-CoV-2 infection are summarized, adding to our knowledge of the spectrum of COVID-19. In addition, preventive measures implemented in endoscopy departments to prevent further dissemination of SARS-CoV-2 infection are proposed.","Arab J Gastroenterol","Musa, Sherief","32253172"],"abstract":["Since December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19), has posed a serious threat to global health and is currently causing a major pandemic. While patients typically present with fever and a respiratory illness, mounting evidence indicates that patients might also report extra-pulmonary manifestations, including those affecting the liver and gastrointestinal tract. This involvement may have important implications to the disease management, transmission, and prognosis, especially in patients with pre-existing hepatic or digestive co-morbidities. In this review, the characteristics and possible explanations of hepatic and gastrointestinal involvement caused by SARS-CoV-2 infection are summarized, adding to our knowledge of the spectrum of COVID-19. In addition, preventive measures implemented in endoscopy departments to prevent further dissemination of SARS-CoV-2 infection are proposed."],"journal":"Arab J Gastroenterol","authors":["Musa, Sherief"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32253172","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ajg.2020.03.002","keywords":["COVID-19","Endoscopy","Gastrointestinal tract","Liver","SARS-Cov-2"],"source":"PubMed","topics":["Prevention","Diagnosis","Mechanism"],"weight":1,"_version_":1663450393423642624,"score":44.48312},{"pmid":32273621,"title":"If a coronavirus vaccine arrives, can the world make enough?","text":["If a coronavirus vaccine arrives, can the world make enough?","Nature","Khamsi, Roxanne","32273621"],"journal":"Nature","authors":["Khamsi, Roxanne"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32273621","week":"202015|Apr 06 - Apr 12","doi":"10.1038/d41586-020-01063-8","keywords":["SARS-CoV-2","Vaccines"],"source":"PubMed","topics":["General Info"],"weight":1,"_version_":1663712077906182144,"score":42.961174},{"pmid":32240303,"title":"Electronic Personal Protective Equipment: A Strategy to Protect Emergency Department Providers in the Age of COVID-19.","text":["Electronic Personal Protective Equipment: A Strategy to Protect Emergency Department Providers in the Age of COVID-19.","Emergent policy changes related to telemedicine and the Emergency Medical Treatment and Labor Act (EMTALA) during the novel coronavirus pandemic (COVID-19) have created opportunities for technology-based clinical evaluation, which serves to conserve personal protective equipment (PPE) and protect emergency providers. We define electronic personal protective equipment (ePPE) as an approach using telemedicine tools to perform electronic medical screening exams while satisfying EMTALA. We discuss the safety, legal, and technical factors necessary for implementing such a pathway. This approach has the potential to conserve PPE and protect providers while maintaining safe standards for medical screening exams in the ED for low risk patients in whom COVID-19 is suspected.","J Am Med Inform Assoc","Turer, Robert W","Jones, Ian","Rosenbloom, S Trent","Slovis, Corey","Ward, Michael J","32240303"],"abstract":["Emergent policy changes related to telemedicine and the Emergency Medical Treatment and Labor Act (EMTALA) during the novel coronavirus pandemic (COVID-19) have created opportunities for technology-based clinical evaluation, which serves to conserve personal protective equipment (PPE) and protect emergency providers. We define electronic personal protective equipment (ePPE) as an approach using telemedicine tools to perform electronic medical screening exams while satisfying EMTALA. We discuss the safety, legal, and technical factors necessary for implementing such a pathway. This approach has the potential to conserve PPE and protect providers while maintaining safe standards for medical screening exams in the ED for low risk patients in whom COVID-19 is suspected."],"journal":"J Am Med Inform Assoc","authors":["Turer, Robert W","Jones, Ian","Rosenbloom, S Trent","Slovis, Corey","Ward, Michael J"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32240303","week":"202014|Mar 30 - Apr 05","doi":"10.1093/jamia/ocaa048","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663352135613415424,"score":40.183807}]}